We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Proton Scanning Algorithm Precisely Controls how Radiation Dose is Distributed

By MedImaging staff writers
Posted on 22 Jan 2008
A new proton scanning dose algorithm provides clinicians with greater control over how proton beams are used to target tumors and other abnormalities. More...


Varian Medical Systems (Palo Alto, CA, USA) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the new algorithm, which has been incorporated into Varian's Eclipse treatment planning software. The algorithm now makes it possible to plan for intensity-modulated proton therapy by optimizing dose distributions in three dimensions to protect surrounding healthy tissues.

This proton scanning technique improves on current proton delivery methods that require a therapist to enter and exit the treatment room numerous times throughout a treatment to adjust physical compensators for processing proton beams. "With proton scanning and intensity-modulation, this cumbersome process can be completely eliminated,” said Jeff Amacker, Varian's business manager for treatment planning products.

Proton therapy uses a particle accelerator to generate a beam of protons and deposit them accurately within tumors while sparing adjacent healthy tissues and organs. Unlike the more common photon radiotherapy, with beams that pass all the way through the patient's body, proton therapy beams can be designed to stop and distribute most of their radiation dose at the depth of the tumor. This makes it possible to improve specific cancer treatments by protecting more healthy tissue and thus reduce short- and long-term side effects in cases where surrounding healthy tissues are particularly sensitive to radiation. Radiation oncology experts estimate that about 10% of the patients can benefit from having all or some of their treatment with protons.

With the addition of the proton-scanning dose algorithm, Eclipse, a very fast, versatile, and widely-used radiotherapy treatment planning system, continues to expand on its functionality as a single system for state-of-the-art proton, photon, electron, and brachytherapy treatment planning. Within the Eclipse planning environment, clinicians can combine and compare plans for any and all of these treatment approaches, to arrive at an optimal strategy for helping patients.


Related Links:
Varian Medical Systems

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
Monitor/Defibrillator
Zenix
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Aliya EX Generator for surgical ablation of soft tissue (Photo courtesy of Galvanize Therapeutics)

Next-Generation PEF System Delivers Larger Ablation Zones for Soft-Tissue Procedures

Interventional teams often need soft-tissue ablation options that can be performed percutaneously or endoscopically while minimizing collateral injury and preserving procedural workflow.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.